ArticleJournal of applied clinical medical physics2025
Dosimetric and robustness evaluation of biaxially rotational dynamic radiation therapy with robust optimization.
Article in Journal of applied clinical medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Beyond Couch Correction in Head and Neck Radiotherapy: A Narrative Review of Action-Oriented Positioning Management.Cancers · 2026Review
- Dosimetric advantages of non-coplanar volumetric modulated arc therapy (VMAT) using biaxially rotational dynamic radiation therapy compared with coplanar VMAT in prostate stereotactic body radiation therapy with focal boost.Japanese journal of radiology · 2026Article
- Dosimetric and robustness evaluation of biaxially rotational dynamic radiation therapy with robust optimization.Journal of applied clinical medical physics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundStudies suggest that integrating robust planning and noncoplanar volumetric modulated arc therapy (VMAT) may be a useful strategy for maximizing the benefits of dose delivery while maintaining resilience to uncertainty; however, the robustness of target coverage and the dose-sparing performance for organs at risk of techniques that combine dynamic trajectory irradiation and robust planning have not been fully investigated. PURPOSE: We aimed to evaluate the combination of biaxially rotational dynamic radiation therapy (BROAD-RT) with robust planning to improve the dosimetric outcomes and robustness of head and neck cancer (HNC) radiation therapy.
methodsWe retrospectively analyzed 10 patients with oropharyngeal and hypopharyngeal cancers who were treated with VMAT. Robust-VMAT, Robust-Non-Coplanar-VMAT (Robust-NC-VMAT), and Robust-BROAD-RT plans were generated using the RayStation treatment planning system, with patient setup uncertainties of 3-5 mm in each of the three axial directions (left-right, anterior-posterior, and superior-inferior) applied to the clinical target volume (CTV) during robust optimization. The prescribed doses were 70 and 56 Gy in 35 fractions for high- and low-risk CTVs, respectively. Dosimetric parameters, including dose coverage for the CTVs and organ at risk (OAR) sparing, were compared between the plans. Robustness was evaluated using eight uncertainty scenarios, each generated by applying ± 1.7 mm translational shifts simultaneously along all three orthogonal axes (left-right, anterior-posterior, and superior-inferior), resulting in a combined vector displacement of approximately 3 mm.
resultsThe Robust-BROAD-RT plans significantly reduced the mean doses to the contralateral and ipsilateral parotid glands and the oral cavity by 8.17, 6.20, and 3.03 Gy, respectively, compared to the Robust-VMAT plans (p < 0.001, p < 0.001, and p = 0.002, respectively). Similarly, the Robust-BROAD-RT plans achieved significantly lower doses to the parotid glands and the oral cavity compared to the Robust-NC-VMAT plans (p = 0.004, p = 0.014, and p = 0.014, respectively). No significant differences were observed in the target coverage indices (D98, D50), conformity index (CI), or homogeneity index (HI) among the three techniques. The worst-case scenario analysis showed that the degree of deterioration in these target-related parameters did not differ significantly among the Robust-BROAD-RT, Robust-VMAT, and Robust-NC-VMAT plans.
conclusionsThe Robust-BROAD-RT plan achieved a further reduction in doses to the parotid and oral cavities while maintaining robustness comparable to that of conventional Robust VMAT planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.